Endymed Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ENDY.TA research report →
Price Chart
About the company
Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.
- CEO
- Yossi Bar-On CPA
- IPO
- 2007
- Employees
- 46
- HQ
- Freehold, NJ, US
Get TickerSpark's AI analysis on ENDY.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $44.05M
- P/E
- 26.76
- PEG
- -0.29
- P/S
- 0.65
- P/B
- 0.97
- EV/EBITDA
- 4.09
- Div Yield
- 0.00%
- Gross Margin
- 51.20%
- Op Margin
- 4.05%
- Net Margin
- 2.43%
- ROE
- 3.69%
- ROIC
- 2.87%
Latest fiscal year · YoY change
- Revenue
- $22.78M+6.8%
- Gross Profit
- $11.66M+15.9%
- Op Income
- $922.00K
- Net Income
- $553.00K-34.9%
- EPS
- $0.04-35.5%
- OCF Growth
- -671.8%
- FCF Growth
- -182.0%
- 52W High
- $355.00
- 52W Low
- $3.20
- 50D MA
- $287.07
- 200D MA
- $276.83
- Beta
- -0.29
- RSI (14)
- 64
- Avg Volume
- 11.55K
No earnings-call transcripts are available for ENDY.TA yet.
- Free Float
- 36.6%
- Shares Outstanding
- 13.76M
- Float Shares
- 5.04M
Our ENDY.TA coverage
Recent articles, reports, and earnings notes.
No research on ENDY.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ENDY.TA report →